Zura Bio LTD 8-K filings

Zura Bio Limited has engaged WithumSmith+Brown as its new independent auditor, replacing Marcum LLP, following the completion of a business combination.

Zura Bio's senior management will participate in several investor conferences throughout February to discuss their clinical-stage biotechnology programs.

Zura Bio presented an update at the J.P. Morgan Healthcare Conference, emphasizing its dual-pathway approach to treating autoimmune diseases and its clinical pipeline.